Blossom Capital Partners

Invest with Blossom Capital Partners
  • Adtech
  • Agnostic
  • Deeptech
  • Fintech
  • Foodtech
  • Healthtech
  • HRtech
  • Infratech
  • Insurtech
  • Legaltech
  • Martech
  • Mediatech
  • Regtech
  • Wealthtech
  • AI
  • Automation
  • B2B
  • B2E
  • Collaboration
  • Data & Analytics
  • Enterprise Software
  • Payments
  • Productivity
  • SaaS

About

ABOUT US

Our Blossom Capital Partners angel syndicate was created to help make early-stage startup investing more accessible to more investors.

We back and mentor Australian tech founders, and want to share our investments with more investors through this syndicate.

As Operator Angels, our superpower is bridging corporate wisdom with startup innovation. We've been Angel investing in early-stage tech startups for several years, and more recently mentoring and assisting founders to raise capital.

We get early access to ambitious and innovative early-stage tech startups and talented founders that are solving real problems. 

We encourage syndicate members to be active with us and the startups we invest in.

 

OUR APPROACH

We aim to run 4-6 deals per year. 

As a duo with limited time to help our portfolio founders and investing our own money, our approach is quality over quantity. We don't run a Fund or PE, so need to be more selective about vetting deals to back and share with the syndicate. 

Our deal flow for investments comes from:

  • our own network of investors, founders and Boards,
  • being active in industry engagement, and
  • VC and Family Office friends.

 

INVESTMENT THESIS

While we have invested in a range of Australian early-stage tech across different verticals, we lean into certain opportunities due to our own experience and networks: FinTech, MarTech, AdTech, Productivity or Enterprise SaaS, DeepTech

We try to keep it simple for finding target investments:

  1. It's early-stage tech and Australian
  2. Proven (or exited) founders
  3. Validated market fit
  4. Large attainable market (aka "VC scale")
  5. We'd use it ourselves!

Of course, we still evaluate a range of key criteria (eg. Team, Distribution, Traction and Metrics, Technology... and importantly, Value/Valuation).

Things you probably won't see from us: bio/medtech, services or agencies, hardware-only, crypto, wagering, B2C, DTC, mobile apps, or games.
 

Team

Joanna Zaslavsky (B. Psych.)

Joanna's background was originally in Private Banking where she started and led a new division for NAB Private, servicing high networth clients to find new investments. Joanna then headed up Investor Relations in the Development Finance sector, working on multi-million Development projects. 

It wasn't until Joanna's work with the $100Mn Bio Capital Impact Fund (BCIF) where she sourced high networth investors for BioTech technologies, that she began working with early-stage startups.  From there, Joanna has assisted multiple startups raise capital, eventually starting to invest in her own portfolio of early-stage companies.

 

Vadim Petrichenko (B. Bus. Law)

Vadim brings 20yrs of corporate Commercial and Procurement leadership, leading national and global teams. He has led and negotiated large-scale commercial deals and strategies in complex, fast-paced organisations across multiple industries: IT; Retail; Franchise; Finance; Infrastructure; Telecommunications, and Manufacturing.

Vadim's corporate roles have allowed him to be an impactful 'intrapreneur', which has led to becoming an operator angel investor. 

Prior to completing his Bachelor of Business Law, Vadim also studied Software Engineering.